Reverse-phase evaporation lipid vesices (REV) liposomes, consisting of phosphatidyl choline and stearylamine in 13 molar ratio, encapsulated approximately 30% of exogenously supple recombinant DNA vector, pBR322. The DNA sequestered in REV lposomes was highly tolerant to DNase.
Artificial lipid vesicles (liposomes) have been used as vehicles for transferring biologically active materials such as proteins, mRNA, and chromosomes into mammalian cells in culture (5, 14, 16, 18) . Some instances have been presented demonstrating liposome-mediated transfer of materials into plant protoplasts. These include a fluorescent marker, chloroplasts via multilamellar lipid vesicles (3, 6, 21) , and bacterial RNA entrapped in large unilamellar lipid vesicles (13) .
Special attention has been paid to the transfer of genetic materials, particularly recombinant vehicles (plasmid DNA), into plant protoplasts with the aid of liposomes. Also, several attempts have been made to insert bacterial plasmids into plant protoplasts (7, 12) . In most cases, the major problem encountered in the transfer of naked DNA into protoplasts seems to be the degradation of DNA molecules before their transfer to the protoplasts (4, 10, 15) . From this point of view, liposomes have been considered as a potential candidate to overcome such problems. Lurquin (11) demonstrated the efficient incorporation of plasmid DNA into protoplasts mediated by multilamellar lipid vesicles.
We selected REV' liposomes because of their large encapsulation capacity (20) . This paper describes some critical parameters for encapsulation of pBR322 plasmid DNA by REV liposomes and the fate of liposome-encapsulated plasmid DNA in plant protoplasts.
'Abbreviations: REV, reverse-phase evaporation lipid vesicles; PBS, phosphate-buffered saline; PB, phosphate buffer.
MATERIALS AND METHODS
Protoplasts. Protoplasts were prepared from suspension cultured cells of Daucus carota by a modified method previously described (22) . Cultured cells, S to 6 days old, were incubated in a solution containing 1% Cellulase Onozuka (Kinki Yakult MFG, Nishinomiya, Japan), 0.2% Macerozyme (Kinki Yakult), 0.01% Pectolyase (Seishin Pharmaceutical, Nagareyama, Japan), and 0.5 M mannitol. After incubation for 2 to 3 h at 25 C with gentle shaking, protoplasts were passed through two layers of Miracloth (Calbiochem) and centrifuged at 150g for 1.5 min. Pelleted protoplasts were suspended in 0.5 M mannitol and recentrifuged. Protoplasts were thus washed at least twice and maintained in an appropriate buffer solution containing 0.5 M mannitol.
Preparation of I'HIpBR322. [3H] pBR322 was prepared by a method reported elsewhere (1). Specific radioactivity obtained was 62,000 cpm/,ug DNA.
REV Liposomes. REV liposomes were prepared according to a modified method developed by Szoka and Papahadjopoulos (20) .
Hydrogenated phosphatidyl choline (egg lecithin) (3.2 ,tmol; 2.5 mg) and stearylamine (0.95 ,umol; 0.265 mg) (both from P. L. Biochemical, Milwaukee, WI) were mixed in chloroform contained in a 10-ml round-bottom flask. Chloroform was evaporated under N2 gas with a gentle rotation. When a film on the inside wall of a flask was completely dried, it was dissolved in 0.3 ml ethyl ether and 0.15 ml 0.5 M mannitol plus one-tenth PBS (13.7 mM NaCl, 0.26 mm KCI, 0.64 mm Na2HPO4, 0.14 mm KH2PO4) containing 0.1 to 1 ,ug [3H]pBR322. Then the flask was placed in an ice-cold water bath with 2-min sonication and left on ice. After 30 min, the flask was rotated at 200 rpm under N2 gas to evaporate the remaining ether. Liposome suspension was centrifuged at 3,000g for 10 min to remove small vesicles. This centrifugation was repeated at least twice. Large liposomes containing plasmid DNA (liposome-DNA) in a pellet fraction were resuspended in 1 ml of an appropriate buffer solution.
Incubation of Liposome-DNA with Protoplasts. One-hundred ,ul of protoplast suspension (106_107 protoplasts/ml) in 100 mm PB (pH 7.0) plus 0.5 M mannitol were mixed with an equal volume of PB-0.5 M mannitol solution containing liposome-DNA in a 0.8- (9) . After electrophoresis at 4 mamp/ gel, the gel was cut into a 2-mm slice and transferred to a scintillation vial containing 0.5 ml distilled H20, which, in turn, was placed on a hot plate to melt the agarose. To each vial was added 5 ml scintillation cocktail, and radioactivity was measured by a liquid scintillation counter.
RESULTS
Plasmid DNA Encapsulated in REV Liposomes. An electrophoretic profile of the pBR322-preparation employed in this investigation is shown in Figure IA . This preparation contained covalently closed circular DNA and open circular DNA (possibly mixed with some linear form) in 3:1 ratio. Also, the same preparation contained a trace amount of chromosomal DNA. Since brief sonication is involved in the preparation of REV liposomes, DNA preparation was sonicated for 2 min before looking for any destructive effects of sonication on DNA. As can be seen in Figure  1B ml DNase for 15 min at 25 C, all the large molecules were depolymerized (Fig. IC) . Table I summarizes the results of DNase treatment of liposomeencapsulated pBR322. When DNA encapsulated in liposomes was treated with DNase, 82% was recovered as acid-insoluble materials. In contrast, the same treatment caused extensive degradation of DNA in the mixture of liposomes and DNA as well as in the pure DNA control.
Encapsulation Efficiency. During our investigation, we assessed the encapsulation efficiency of REV liposomes for pBR322 by comparing several parameters. One such critical factor turned out to be the buffer solution. Table II demonstrates that one-tenth PBS is a more favorable medium than is PB in terms of encapsulation ability of liposomes.
Influence of Buffers on the Survival and Aggregation of Protoplasts Mixed with Liposomes. Prior to carrying out experiments on the transfer of liposome-encapsulated DNA into protoplasts, an appropriate buffer solution needed to be developed. Initially, we employed one-tenth PBS containing 0.5 M mannitol for liposome transfer into protoplasts. However, high concentration of phosphatidyl choline (liposomes) induced aggregation of protoplasts, eventually causing the disruption of protoplasts at 2.4 ,umol phosphatidyl choline ( Fig. 2A) . In contrast, PB did not lower survival ofprotoplasts treated with liposomes at the concentrations tested but caused slight aggregation of protoplasts (Fig. 2B) . As has been stated earlier, encapsulation of DNA by REV liposomes using PB was less efficient than using one-tenth PBS. Thus, liposomes were prepared first with one-tenth PBS-0.5 M mannitol, then mixed with protoplasts in PB-0.5 M mannitol. The result presented in Figure 2C demonstrates no decrease in protoplast survival as well as no distinctive aggregation phenomenon by this two step procedure. Hereafter, we followed this procedure, and the liposome-DNA suspended in PB-0.5 M mannitol was mixed with a given amount of protoplast suspension in PB-0.5 M mannitol.
Uptake of DNA by Protoplasts. Protoplasts which had been incubated with liposome-DNA were purified using 0.5 M mannitol-0.5 M sucrose density gradient centrifugation, as described in Handling and observation of protoplasts were the same as in (a). (c). REV liposomes were made using one-tenth PBS-0.5 M mannitol and, in turn, were mixed with 106 to 107 protoplasts/ml suspended in PB-0.5 M mannitol. "Materials and Methods." TCA-insoluble uptake of pBR322 by protoplasts was found to be 6%, whereas liposome-mediated uptake of plasmid DNA was 11.8% (Table III) .
Fate of DNA Molecules in Protoplasts. After 5-h incubation of protoplasts with liposome-DNA, about 50%o of the molecules trapped in 0.8% agarose were accounted for by open circular and covalently closed circular forms of pBR322 (Fig. 3B) control, resulted in distinct separation of each molecular form in the original quantitative ratio (Fig. 3A) . DISCUSSION REV liposomes similar to those employed in this investigation are capable of encapsulating 15.6 ,ul aqueous phases per mg weight of lipid (20) . Inasmuch as we used 150 ,ul total aqueous phase per 2.5 mg phosphatidyl choline (39 ,ul encapsulation capacity), 26% encapsulation can be estimated. This value is of about the same order as that reported in Table II .
Among the other liposomes tested in this investigation, large unilamellarliposomes (17) contained as much as 10%lo ofexogenous pBR322, and less than 5% was sequestered by multilameliar lipid vesicles (21) .
Of particular interest in the present investigation is the observation that an appropriate buffering system must be used for this type of experiment. The harmful effect of one-tenth PBS on protoplast survival may be due to the presence of NaCl in PBS. Our unpublished work suggests that some monocation, such as sodium or potassium, caused aggregation of protoplasts in the presence ofpositively charged lipid vesicles. Nevertheless, the high encapsulation activity using one-tenth PBS-0.5 M mannitol allowed us to use the two-step buffering procedure reported above. PBS was chosen, because we were successful in the insertion of a fluorescent material into protoplasts via liposomes using the same buffer (21) .
Several reagents have been reported which protect plasmid DNA from degradation, including poly-L-ornithin (8) and Zn2+ (12, 19) . Thus, the encapsulation technique using REV liposomes can be substituted for these reagents. Our experiments indicated extensive degradation of foreign DNA when protoplasts were kept in a solution containing free DNA (nonencapsulated DNA) over 5-h incubation periods (unPlant Physiol. Vol. 68, 1981 published data). This lead us to look for any favorable effects of liposome-DNA transfer system in terms of protecting exogenous DNA which had moved inside protoplasts. The time-course analysis of the fate of pBR322 DNA molecules in protoplasts indicates that some degradation and possible reutilization of inserted DNA occurred. In 5-h incubation, two molecular forms ofplasmid DNA were observed. However, progressive incubation, up to 20 h, lead to the eventual disappearance of open circular DNA, while the covalently closed circular DNA was maintained as stable molecules.
We are in the process of investigating whether this DNA still contains biologically active sequences, in particular, tetracycline resistance (2).
